Posted by john on July 31st, 2006 — in Aldara Top News
The Quigley Corporation (Nasdaq: QGLY - News) today reported net sales of $6.2 million, for the second quarter ended June 30, 2006, compared to $8.8 million reported for the same period in 2005. For the six-months ended June 30, 2006, net sales were $16.4 million compared to $20.6 million reported for the same period in […]
No Comments »
Posted by john on July 30th, 2006 — in Aldara Top News
3M announced today that Aldara Cream is a featured topic in multiple presentations by leading researchers at the American Academy of Dermatology’s (AAD) ACADEMY 06 meeting in San Diego, July 26-30. Aldara Cream is the first and only immune response modifier indicated for the treatment of precancerous actinic keratosis, superficial basal cell carcinoma and external […]
No Comments »
Posted by john on July 24th, 2006 — in Aldara Top News
Biogen Idec and Elan Corporation, plc today announced the commercial availability of Tysabri® (natalizumab) for the treatment of relapsing forms of multiple sclerosis (MS) in the U.S.
As previously announced, the U.S. Food and Drug Administration (FDA) approved the supplemental Biologics License Application (sBLA) for the reintroduction of Tysabri as a monotherapy treatment for relapsing forms […]
No Comments »
Posted by john on July 23rd, 2006 — in Aldara Top News
This is the first microbicide clinical development program specifically for prevention of genital herpes to be funded by the US National Institutes of Health (NIH). Starpharma also understands that this is the first investigational new drug (IND) application to be submitted to the FDA for this indication
Completion of the IND review period clears the way […]
No Comments »
Posted by john on July 17th, 2006 — in Aldara Top News
According to recently published research from the United States, pancreatic cancer xenografts can be treated with a conditionally replicating herpes simplex derived virus.
“Pancreatic cancer is a devastating disease that is almost universally fatal because of the lack of effective treatments,” wrote X.P. Fu and colleagues, Baylor College of Medicine.
They continued, “We recently constructed a novel […]
No Comments »
Posted by john on July 15th, 2006 — in Aldara Top News
Glycoprotein B (gB) is the most conserved component of the complex cell-entry machinery of herpes viruses.
A crystal structure of the gB ectodomain from herpes simplex virus type 1 reveals a multidomain trimer with unexpected homology to glycoprotein G from vesicular stomatitis virus (VSV G).
An {alpha}-helical coiled-coil core relates gB to class I viral membrane fusion […]
No Comments »
Posted by john on July 11th, 2006 — in Aldara Top News
Genital herpes is caused by a sexually transmitted virus, often leading to blisters on or near the genitals or rectum. These blisters eventually open into painful sores that take several weeks to heal. Over time, outbreaks tend to become less severe and last for shorter periods.
Although many people with genital herpes may not even know […]
No Comments »
Posted by john on July 7th, 2006 — in Aldara Top News
- Biopharmaceutical Start-Up With Lead Product in Phase I/II Names Experienced Pharma Industry Players
LTKfarma, a biopharmaceutical company focused on developing and marketing cell therapy products derived from modified T-cells to treat leukemia and autoimmune diseases, announced today its creation and the appointment of its advisory board.
“The know-how and experience of our advisory board members, […]
1 Comment »
Posted by john on July 5th, 2006 — in Aldara Top News
Quest Diagnostics Inc. said Wednesday it completed the previously announced purchase of privately owned Focus Diagnostics Inc. for $185 million cash.
Focus Diagnostics, based in Herndon, Va., makes products that diagnose diseases such as herpes, Lyme disease, West Nile Virus and SARS.
Click to learn more…
Quest said the acquisition will not materially affect earnings in 2006 except […]
2 Comments »
Posted by john on July 3rd, 2006 — in Aldara Top News
My husband and I are expecting our first child in four months. I am 32. I have had herpes since I was 26. Since the first outbreak, I have perhaps two outbreaks a year, and they last around five days. My husband does not have, nor has he ever had, any signs of herpes. We […]
1 Comment »